Trials / Unknown
UnknownNCT00547469
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Effectiveness of DDP733 in Female Patients With Irritable Bowel Syndrome With Constipation
- Status
- Unknown
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 360 (estimated)
- Sponsor
- Dynogen Pharmaceuticals · Industry
- Sex
- Female
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the safety and effectiveness of the investigational drug DDP733 in treating female patients with IBS-c. A placebo control will be utilized.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DDP733 |
Timeline
- Start date
- 2007-10-01
- First posted
- 2007-10-22
- Last updated
- 2008-04-08
Locations
69 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT00547469. Inclusion in this directory is not an endorsement.